pilot with a local focus
The first phase is already under way, involving nurses working in community-based primary healthcare settings in the Western Cape.
Rather than simply introducing an international platform into South Africa, the pilot will focus on adapting Dr Sophia AI to local healthcare needs and working conditions.
This includes incorporating South Africa’s Essential Medicines Lists and relevant clinical guidelines, refining the technology for local care pathways, and testing its language capabilities in the way patients and healthcare professionals communicate in practice.
The pilot will also examine whether streamlining operations could help small healthcare businesses grow their revenue streams.
Insights gathered during this phase will inform further improvements to the platform for the South African context and help determine its potential for wider deployment.
The work therefore extends beyond technology. It is also about understanding how digital tools can function in real healthcare settings, where local guidelines, language and everyday operational realities matter.
Connecting commercial growth with social impact
A key part of the partnership is the development of a funding model that could complement traditional grant funding.
Tshikululu and Dr Sophia AI are exploring a concept in which a percentage of future revenue generated through the platform’s commercial deployment would be directed into a grant fund.
That fund would support initiatives aimed at expanding access to quality healthcare and supporting the growth of small, medium and micro enterprises (SMMEs).
Tshikululu would contribute its experience in social investment and fund management to the proposed model.
If developed, the approach could create a link between commercial adoption and community benefit. Revenue generated through the technology could help support further healthcare initiatives, creating a potential funding source alongside conventional grants.
The model is still being designed. Its development will depend on collaboration with organisations interested in helping shape and participate in the initiative.
Keeping clinical oversight and regulation in focus
As AI becomes more prominent in healthcare, appropriate oversight remains essential.
According to the supplied partnership information, Dr Sophia AI complies with the United States Food and Drug Administration’s Clinical Decision Support Software requirements. It is also registered in Australia as Class I Software as a Medical Device for clinical decision support.
Its deployment in South Africa will also align with applicable requirements under the Protection of Personal Information Act (POPIA), the South African Health Products Regulatory Authority (SAHPRA) and the Health Professions Council of South Africa (HPCSA).
These regulatory and governance considerations sit alongside the platform’s intended role: to assist clinical decision-making while keeping healthcare professionals responsible for reviewing and approving recommendations.
A shared vision for more equitable healthcare
For Tshikululu Social Investments, the initiative is about bringing technology into the realities of frontline healthcare delivery.
“Where you live, the language you speak or the availability of healthcare professionals in your community should not determine the quality of healthcare you can access,” says Leanne Emery-Hunter, CEO of Tshikululu Social Investments.
“This pilot is about taking an established AI-assisted clinical platform and embedding it in the South African context — our clinical guidelines, our languages and the realities of frontline healthcare delivery.”
Julia McCann, GM of Dr Sophia AI, says the partnership offers an opportunity to explore how a global platform can be adapted to different healthcare systems and communities.
“Healthcare is deeply local, but the challenge of delivering consistent, high-quality care is global,” says McCann.
“Our ambition is to build technology that can support healthcare professionals across very different health systems, languages and communities. South Africa is an important opportunity to demonstrate how a global platform can be meaningfully localised — combining international clinical capability with the guidelines, languages and realities of care on the ground.”
The partnership reflects a wider approach to social investment: bringing technology, commercial expertise and social-sector experience together to address persistent challenges while exploring funding mechanisms that can complement traditional grant-making.
Emery-Hunter describes this collaboration as an opportunity to rethink how social impact is supported.
“This is the kind of social innovation we want to enable,” she says. “It brings together technology, frontline expertise and a new approach to funding around a very practical question: how do we get better healthcare closer to people who have historically had the least access to it? We believe that will require collaboration, continuous learning and new ways of thinking about how social impact is funded.”
What comes next?
The Western Cape pilot will provide insights into how Dr Sophia AI can be localised, used in community healthcare settings and potentially support the sustainability of smaller healthcare businesses.
At the same time, Tshikululu and Dr Sophia AI are inviting funders, healthcare organisations, corporates and other potential partners to engage with the initiative and help shape its next phase.
The broader ambition is to explore whether commercial use of AI-assisted clinical support can help generate ongoing funding for initiatives that improve access to quality healthcare in underserved communities.
The pilot is an early step, rather than a guarantee of wider rollout or future funding outcomes. Its findings will help inform what comes next.
Ultimately, the partnership is asking an important question: can healthcare technology do more than support clinical work — can it also help build more sustainable ways to bring quality care closer to the people who need it most?
